Cite
Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
MLA
Nardelli, Silvia, et al. “Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 15, no. 6, June 2017, pp. 934–36. EBSCOhost, https://doi.org/10.1016/j.cgh.2016.10.028.
APA
Nardelli, S., Lattanzi, B., Torrisi, S., Greco, F., Farcomeni, A., Gioia, S., Merli, M., & Riggio, O. (2017). Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 15(6), 934–936. https://doi.org/10.1016/j.cgh.2016.10.028
Chicago
Nardelli, Silvia, Barbara Lattanzi, Sabrina Torrisi, Francesca Greco, Alessio Farcomeni, Stefania Gioia, Manuela Merli, and Oliviero Riggio. 2017. “Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 15 (6): 934–36. doi:10.1016/j.cgh.2016.10.028.